查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2086215

營養基因組學市場：2026-2032年全球市場預測（按產品、方法、技術、應用和最終用戶分類）

Nutrigenomics Market by Offering, Technique, Technology, Application, End-User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，營養基因組學市場將成長至 211844 億美元，複合年成長率為 17.83%。

主要市場統計數據
基準年 2025 6.7141億美元
預計年份：2026年 7.8588億美元
預測年份 2032 211844億美元
複合年成長率 (%) 17.83%

營養基因組學正從小眾的健康概念發展成為一個以數據驅動的精準營養領域，它將基因變異與飲食反應、代謝風險和個人化健康指導聯繫起來。數十年的基因組研究、美國國家人類基因組實驗室報告的DNA定序成本大幅下降，以及與飲食相關的非傳染性疾病負擔日益加重（世界衛生組織指出，這些疾病是全球死亡的主要原因之一），都為這一領域的發展提供了支持。

市場需求受消費者對個人化營養方案、預防性醫療保健體係以及食品、營養補充劑、診斷和數位健康領域相關人員的影響，這些利益相關者正將基因學見解融入產品開發中。科學可信賴的營養基因組學需要檢驗的基因-飲食關聯、負責任的解讀、透明的知情同意，以及明確區分循證建議和生活方式行銷宣傳。

營養基因體學的變革性變化

營養基因組學領域正經歷一場變革，其驅動力包括價格親民的基因分型、多體學分析、穿戴式健康數據以及消費者對預防醫學日益成長的興趣。服務提供者正從基於單基因的膳食建議轉向更廣泛的模式，將遺傳學和生物標記、微生物組譜、生活方式、膳食攝入量和臨床病史等因素結合起來。

人工智慧（AI）的累積影響

人工智慧 (AI) 透過識別基因組變異、飲食攝取、血液生物標記、微生物組數據、連續血糖監測和生活方式記錄中的模式，正在擴展營養基因組學的分析能力。 AI 驅動的模型可以改善大規模個人化方案，支援營養指導，並幫助研究人員優先考慮基因-營養交互作用以進行進一步檢驗。

影響實施的區域趨勢

北美憑藉其先進的基因檢測基礎設施、對數位健康的高度參與、對預防性健康維護的既有需求以及消費者對基於DNA的健康資訊的熟悉程度，在營養基因組學的應用方面處於領先地位。歐洲的特點是嚴格的隱私權管治、公共衛生營養政策、臨床研究網路以及對實證聲明的強烈期望。在亞太地區，受中產階級健康支出成長、基因組學能力提升、應對人口老化以及預防與飲食相關的慢性疾病等因素的推動，中國、日本、印度、韓國和澳洲的市場正在擴張。

針對特定策略群體的洞察

在東協市場，都市化、行動優先的醫療保健服務以及日益增強的營養意識，催生了對價格合理、基於DNA的健康和預防性醫療保健服務的需求，使其重要性日益凸顯。海灣合作理事會（GCC）國家正透過國家級舉措計劃、高額醫療費用支出以及針對肥胖、糖尿病和心血管代謝疾病的預防項目，建構精準醫療框架。

各國市場趨勢

美國是營養基因組學的主要市場，這主要得益於消費者直接檢測的普及、數位醫療的廣泛應用、對預防性健康保健的需求，以及蓬勃發展的膳食補充劑和機能性食品產業。加拿大則憑藉其在公共衛生、研究能力和注重隱私保護的推廣應用方面的優勢，在營養基因組學領域中佔據領先地位。同時，墨西哥和巴西也看到了成長潛力，這主要源於人們對肥胖、糖尿病、心血管疾病預防以及符合當地文化習慣的營養指導日益成長的關注。

為行業領導者提供的實用建議

產業領導者應優先發展具有臨床意義的營養基因組學，投資於檢驗的遺傳和膳食證據、透明的報告機制，並為消費者和臨床醫生設定明確的限制。產品功效聲明必須符合監管要求，並且在證據基於相關性、僅限於特定人群或取決於生活方式或環境背景時，應避免誇大因果關係。

調查方法

本執行摘要基於權威公共衛生機構的二手研究、法律規範、同行評審的科學文獻、基因組學成本趨勢數據以及精準營養、診斷、數位健康和​​機能性食品市場的行業觀察。本分析著重於檢驗的趨勢和有證據支持的市場訊號，而非未經證實的市場規模估算。

結論與策略展望

隨著消費者、臨床醫生和醫療保健系統對與飲食相關的慢性疾病的個人化預防策略的需求日益成長，營養基因組學有望成為實現精準營養的關鍵要素。在科學檢驗、符合倫理的數據利用、全面研究和實際膳食實施能夠協調一致的領域，營養基因組學將迎來最大的發展機會。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：營養基因體學市場：依產品/服務分類

  • 試劑和試劑盒
  • 服務
    • 遺傳諮詢服務
    • 研究與開發服務

第8章：營養基因體學市場：依方法論分類

  • 血
  • 口腔黏膜拭子
  • 唾液

第9章：營養基因體學市場：依技術分類

  • 生物資訊學和數據分析
  • 基因型鑒定
  • 微陣列技術
  • 次世代定序（NGS）
  • 聚合酵素鏈鎖反應（PCR）

第10章：營養基因體學市場：依應用領域分類

  • 癌症預防與管理
  • 疾病管理
    • 心血管系統
      • 膽固醇
      • 高血壓
    • 糖尿病
      • 1型
      • 類型 2
    • 肥胖
  • 個人化營養
  • 運動營養
    • 耐力
    • 訓練結束後
    • 鍛鍊前
  • 體重管理

第11章：營養基因體學市場：依最終用戶分類

  • 診斷檢查室
  • 健身健康中心
  • 醫院和診所
  • 研究和學術機構

第12章：營養基因組學市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：營養基因體學市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 營養基因體學市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Atlas Laboratories Ltd.
  • DNAlife
  • EliteVita
  • Genomics Research and Solutions Pvt Ltd.
  • Genosalut Balear SL
  • Genova Diagnostics Inc.
  • GX Sciences, LLC
  • HOLISTIC HEALTH INTERNATIONAL, LLC
  • LifecodeGx Ltd
  • Mapmygenome
  • myDNA Life Australia Pty Ltd.
  • NuGenomics
  • Nutrigenomix Inc.
  • Randox Health LTD
  • The Gene Box
  • Wellness Psychiatry, PLLC
  • Xcode Life
Product Code: MRR-036C5CF3B557

The Nutrigenomics Market is projected to grow by USD 2,118.44 million at a CAGR of 17.83% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 671.41 million
Estimated Year [2026] USD 785.88 million
Forecast Year [2032] USD 2,118.44 million
CAGR (%) 17.83%

Nutrigenomics is moving from a niche wellness concept to a data-driven segment of precision nutrition, connecting genetic variation with dietary response, metabolic risk, and personalized health guidance. The field is supported by decades of genomic research, the steep decline in DNA sequencing costs reported by the National Human Genome Research Institute, and the growing burden of diet-related noncommunicable diseases, which the World Health Organization identifies as responsible for most global mortality.

Market demand is being shaped by consumers seeking personalized nutrition plans, healthcare systems emphasizing prevention, and food, supplement, diagnostics, and digital health stakeholders integrating genetic insights into product development. Scientifically credible nutrigenomics depends on validated gene-diet associations, responsible interpretation, transparent consent, and clear separation between evidence-based recommendations and lifestyle marketing claims.

Transformative Shifts in Nutrigenomics

The nutrigenomics landscape is being transformed by the convergence of affordable genotyping, multi-omics analytics, wearable health data, and rising consumer interest in preventive care. Providers are shifting from single-gene diet claims toward broader models that combine genetics with biomarkers, microbiome profiles, lifestyle behavior, dietary intake, and clinical history.

Regulation and trust are becoming decisive differentiators. Data privacy rules such as the European Union's General Data Protection Regulation, genetic nondiscrimination protections in the United States, and tighter scrutiny of direct-to-consumer health testing are pushing providers to strengthen consent, clinical validation, cybersecurity, and claims substantiation. This is accelerating collaboration among laboratories, nutrition brands, healthcare providers, insurers, and digital therapeutics platforms.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is expanding the analytical capacity of nutrigenomics by identifying patterns across genomic variants, dietary intake, blood biomarkers, microbiome data, continuous glucose monitoring, and lifestyle records. AI-enabled models can improve personalization at scale, support nutrition coaching, and help researchers prioritize gene-nutrient interactions for further validation.

The cumulative impact is not purely technical; it is also operational and ethical. AI can reduce manual interpretation time and support adaptive recommendations, but biased training data, limited representation in genomic datasets, and insufficient clinical validation can weaken recommendations. Industry leaders must therefore use explainable models, diverse datasets, human expert oversight, secure data governance, and continuous post-market evidence generation to maintain scientific credibility.

Regional Dynamics Shaping Adoption

North America leads nutrigenomics adoption through advanced genetic testing infrastructure, high digital health engagement, established preventive wellness demand, and consumer familiarity with DNA-based health insights. Europe is shaped by rigorous privacy governance, public health nutrition policies, clinical research networks, and strong expectations for evidence-based claims. Asia-Pacific is expanding as China, Japan, India, South Korea, and Australia combine growing middle-class wellness spending with genomics capacity, aging-population priorities, and diet-related chronic disease prevention.

Latin America shows rising opportunity as Brazil and Mexico address obesity, diabetes, and cardiovascular risk, creating demand for personalized dietary interventions that remain affordable and culturally relevant. The Middle East, particularly GCC markets, is investing in genomics, diabetes prevention, national health transformation, and premium wellness services. Africa is earlier in commercialization, but long-term potential is significant as genomic diversity, mobile health adoption, public nutrition initiatives, and precision public health research gradually converge.

Strategic Group Insights

ASEAN markets are gaining relevance as urbanization, mobile-first healthcare access, and rising nutrition awareness create demand for affordable DNA-based wellness and preventive health services. GCC countries are building precision health capacity through national genomics initiatives, high healthcare spending, and prevention programs targeting obesity, diabetes, and cardiometabolic disease.

The European Union remains a benchmark for responsible nutrigenomics because of the General Data Protection Regulation, clinical research standards, and strong consumer protection requirements. BRICS countries are important for scale, genomic diversity, and localized nutrition needs, though affordability, infrastructure maturity, and regulatory consistency vary across members. G7 economies support premium innovation through mature diagnostics, biotechnology investment, academic research, and digital health ecosystems, while NATO countries overlap with many high-income markets where cybersecurity, data sovereignty, and health resilience influence nutrigenomics adoption.

Country-Level Market Signals

The United States is a major nutrigenomics market due to direct-to-consumer testing familiarity, digital health adoption, preventive wellness demand, and strong supplement and functional food sectors. Canada benefits from public health credibility, research capacity, and privacy-conscious adoption, while Mexico and Brazil present growth potential tied to obesity, diabetes, cardiovascular prevention, and increasing interest in culturally adapted nutrition guidance.

In Europe, the United Kingdom, Germany, France, Italy, and Spain combine nutrition research, diagnostics capacity, regulated consumer health markets, and growing demand for personalized wellness, while Russia's opportunity is influenced by scientific capability, data localization considerations, and market access constraints. China and India offer scale, diverse dietary patterns, and rapidly expanding health technology ecosystems; Japan and South Korea bring advanced aging, wellness, and genomics markets; and Australia supports adoption through preventive health awareness, established biotechnology infrastructure, and strong consumer interest in evidence-led nutrition.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically defensible nutrigenomics by investing in validated gene-diet evidence, transparent reporting, and clear limitations for consumers and clinicians. Product claims must align with regulatory expectations and avoid overstating causality where evidence is associative, population-specific, or dependent on lifestyle and environmental context.

Companies should also build interoperable platforms that combine genetics with biomarkers, lifestyle data, microbiome insights, and culturally specific dietary guidance. Strategic partnerships with accredited laboratories, registered dietitians, healthcare providers, and academic researchers can improve trust and implementation. Privacy-by-design architecture, explainable AI, inclusive genomic datasets, consent management, and post-market outcome tracking should be treated as core market-entry requirements rather than optional differentiators.

Research Methodology

This executive summary is developed using secondary research from recognized public health agencies, regulatory frameworks, peer-reviewed scientific literature, genomics cost-trend data, and industry observations across precision nutrition, diagnostics, digital health, and functional food markets. The analysis emphasizes verified trends and evidence-backed market signals rather than unsupported market sizing assumptions.

Research inputs are triangulated across disease-burden data, regulatory developments, technology adoption signals, regional healthcare infrastructure, genomics readiness, and consumer wellness behavior. The methodology evaluates market attractiveness through evidence quality, commercialization readiness, data privacy maturity, affordability, clinical integration, cultural relevance, and capacity for responsible AI-enabled personalization.

Conclusion and Strategic Outlook

Nutrigenomics is positioned to become a key enabler of precision nutrition as consumers, clinicians, and health systems seek more personalized prevention strategies for diet-related chronic disease. The strongest opportunities will emerge where scientific validation, ethical data use, inclusive research, and practical dietary implementation are aligned.

The next phase of market growth will favor organizations that can translate complex genomic, biomarker, lifestyle, and nutritional data into clear, culturally relevant, and clinically responsible guidance. Trust, inclusivity, regulatory compliance, cybersecurity, and measurable health outcomes will define competitive advantage in the global nutrigenomics market.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Nutrigenomics Market, by Offering

  • 7.1. Reagents & Kits
  • 7.2. Services
    • 7.2.1. Genetic Counseling Services
    • 7.2.2. Research & Development Services

8. Nutrigenomics Market, by Technique

  • 8.1. Blood
  • 8.2. Buccal Swab
  • 8.3. Saliva

9. Nutrigenomics Market, by Technology

  • 9.1. Bioinformatics & Data Analytics
  • 9.2. Genotyping
  • 9.3. Microarray Technology
  • 9.4. Next Generation Sequencing (NGS)
  • 9.5. Polymerase Chain Reaction (PCR)

10. Nutrigenomics Market, by Application

  • 10.1. Cancer Prevention & Management
  • 10.2. Disease Management
    • 10.2.1. Cardiovascular
      • 10.2.1.1. Cholesterol
      • 10.2.1.2. Hypertension
    • 10.2.2. Diabetes
      • 10.2.2.1. Type 1
      • 10.2.2.2. Type 2
    • 10.2.3. Obesity
  • 10.3. Personalized Nutrition
  • 10.4. Sports Nutrition
    • 10.4.1. Endurance
    • 10.4.2. Post Workout
    • 10.4.3. Pre Workout
  • 10.5. Weight Management

11. Nutrigenomics Market, by End-User

  • 11.1. Diagnostic Laboratories
  • 11.2. Fitness & Wellness Centers
  • 11.3. Hospitals & Clinics
  • 11.4. Research & Academic Institutes

12. Nutrigenomics Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Nutrigenomics Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Nutrigenomics Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Atlas Laboratories Ltd.
  • 16.2. DNAlife
  • 16.3. EliteVita
  • 16.4. Genomics Research and Solutions Pvt Ltd.
  • 16.5. Genosalut Balear SL
  • 16.6. Genova Diagnostics Inc.
  • 16.7. GX Sciences, LLC
  • 16.8. HOLISTIC HEALTH INTERNATIONAL, LLC
  • 16.9. LifecodeGx Ltd
  • 16.10. Mapmygenome
  • 16.11. myDNA Life Australia Pty Ltd.
  • 16.12. NuGenomics
  • 16.13. Nutrigenomix Inc.
  • 16.14. Randox Health LTD
  • 16.15. The Gene Box
  • 16.16. Wellness Psychiatry, PLLC
  • 16.17. Xcode Life

LIST OF FIGURES

  • FIGURE 1. GLOBAL NUTRIGENOMICS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL NUTRIGENOMICS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL NUTRIGENOMICS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL NUTRIGENOMICS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL NUTRIGENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL NUTRIGENOMICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL NUTRIGENOMICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL NUTRIGENOMICS MARKET SIZE, BY END-USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL NUTRIGENOMICS MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL NUTRIGENOMICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL NUTRIGENOMICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL NUTRIGENOMICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL NUTRIGENOMICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL NUTRIGENOMICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL NUTRIGENOMICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NUTRIGENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL REAGENTS & KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL REAGENTS & KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL REAGENTS & KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL GENETIC COUNSELING SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL GENETIC COUNSELING SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL GENETIC COUNSELING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL RESEARCH & DEVELOPMENT SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL RESEARCH & DEVELOPMENT SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL RESEARCH & DEVELOPMENT SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BUCCAL SWAB MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BUCCAL SWAB MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BUCCAL SWAB MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SALIVA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SALIVA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SALIVA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BIOINFORMATICS & DATA ANALYTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIOINFORMATICS & DATA ANALYTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BIOINFORMATICS & DATA ANALYTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL GENOTYPING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL GENOTYPING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL GENOTYPING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MICROARRAY TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MICROARRAY TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MICROARRAY TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CANCER PREVENTION & MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CANCER PREVENTION & MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CANCER PREVENTION & MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DISEASE MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DISEASE MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CARDIOVASCULAR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CARDIOVASCULAR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CARDIOVASCULAR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CHOLESTEROL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CHOLESTEROL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CHOLESTEROL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HYPERTENSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HYPERTENSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HYPERTENSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL DIABETES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL DIABETES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL DIABETES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL TYPE 1 MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL TYPE 1 MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL TYPE 1 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL TYPE 2 MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL TYPE 2 MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL TYPE 2 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL OBESITY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL OBESITY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL OBESITY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PERSONALIZED NUTRITION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PERSONALIZED NUTRITION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PERSONALIZED NUTRITION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SPORTS NUTRITION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SPORTS NUTRITION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SPORTS NUTRITION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ENDURANCE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ENDURANCE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ENDURANCE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL POST WORKOUT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL POST WORKOUT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL POST WORKOUT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PRE WORKOUT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PRE WORKOUT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PRE WORKOUT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL WEIGHT MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL WEIGHT MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL WEIGHT MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL NUTRIGENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL FITNESS & WELLNESS CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL FITNESS & WELLNESS CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL FITNESS & WELLNESS CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL RESEARCH & ACADEMIC INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL RESEARCH & ACADEMIC INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL RESEARCH & ACADEMIC INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL NUTRIGENOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC NUTRIGENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC NUTRIGENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA NUTRIGENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA NUTRIGENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA NUTRIGENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA NUTRIGENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE NUTRIGENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE NUTRIGENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST NUTRIGENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST NUTRIGENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA NUTRIGENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA NUTRIGENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL NUTRIGENOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN NUTRIGENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN NUTRIGENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 179. GCC NUTRIGENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 180. GCC NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 181. GCC NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 182. GCC NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 183. GCC NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 184. GCC NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. GCC NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 186. GCC NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 187. GCC NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
  • TABLE 188. GCC NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 189. GCC NUTRIGENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION NUTRIGENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION NUTRIGENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS NUTRIGENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS NUTRIGENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 212. G7 NUTRIGENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 213. G7 NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 214. G7 NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 215. G7 NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 216. G7 NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 217. G7 NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. G7 NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 219. G7 NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 220. G7 NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
  • TABLE 221. G7 NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 222. G7 NUTRIGENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 223. NATO NUTRIGENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 224. NATO NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 225. NATO NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 226. NATO NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 227. NATO NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 228. NATO NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 229. NATO NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 230. NATO NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 231. NATO NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
  • TABLE 232. NATO NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 233. NATO NUTRIGENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 234. GLOBAL NUTRIGENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES NUTRIGENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 246. CANADA NUTRIGENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 247. CANADA NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 248. CANADA NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 249. CANADA NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 250. CANADA NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 251. CANADA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 252. CANADA NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 253. CANADA NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 254. CANADA NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
  • TABLE 255. CANADA NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 256. CANADA NUTRIGENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 257. MEXICO NUTRIGENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 258. MEXICO NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 259. MEXICO NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 260. MEXICO NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 261. MEXICO NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 262. MEXICO NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 263. MEXICO NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 264. MEXICO NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 265. MEXICO NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
  • TABLE 266. MEXICO NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 267. MEXICO NUTRIGENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 268. BRAZIL NUTRIGENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 269. BRAZIL NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 270. BRAZIL NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 271. BRAZIL NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 272. BRAZIL NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 273. BRAZIL NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 274. BRAZIL NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 275. BRAZIL NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 276. BRAZIL NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
  • TABLE 277. BRAZIL NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 278. BRAZIL NUTRIGENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 279. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 285. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
  • TABLE 288. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 290. GERMANY NUTRIGENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 291. GERMANY NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 292. GERMANY NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 293. GERMANY NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 294. GERMANY NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 295. GERMANY NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 296. GERMANY NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 297. GERMANY NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 298. GERMANY NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
  • TABLE 299. GERMANY NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 300. GERMANY NUTRIGENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 301. FRANCE NUTRIGENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 302. FRANCE NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 303. FRANCE NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 304. FRANCE NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 305. FRANCE NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 306. FRANCE NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 307. FRANCE NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 308. FRANCE NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 309. FRANCE NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
  • TABLE 310. FRANCE NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 311. FRANCE NUTRIGENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 312. RUSSIA NUTRIGENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 313. RUSSIA NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 314. RUSSIA NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 315. RUSSIA NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 316. RUSSIA NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 317. RUSSIA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 318. RUSSIA NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 319. RUSSIA NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 320. RUSSIA NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
  • TABLE 321. RUSSIA NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 322. RUSSIA NUTRIGENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 323. ITALY NUTRIGENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 324. ITALY NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 325. ITALY NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 326. ITALY NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 327. ITALY NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 328. ITALY NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 329. ITALY NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 330. ITALY NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 331. ITALY NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
  • TABLE 332. ITALY NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 333. ITALY NUTRIGENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 334. SPAIN NUTRIGENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 335. SPAIN NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 336. SPAIN NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 337. SPAIN NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 338. SPAIN NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 339. SPAIN NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 340. SPAIN NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 341. SPAIN NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 342. SPAIN NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
  • TABLE 343. SPAIN NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 344. SPAIN NUTRIGENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 345. CHINA NUTRIGENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 346. CHINA NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 347. CHINA NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 348. CHINA NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 349. CHINA NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 350. CHINA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 351. CHINA NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 352. CHINA NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 353. CHINA NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
  • TABLE 354. CHINA NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 355. CHINA NUTRIGENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 356. INDIA NUTRIGENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 357. INDIA NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 358. INDIA NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 359. INDIA NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 360. INDIA NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 361. INDIA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 362. INDIA NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 363. INDIA NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 364. INDIA NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
  • TABLE 365. INDIA NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 366. INDIA NUTRIGENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 367. JAPAN NUTRIGENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 368. JAPAN NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 369. JAPAN NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 370. JAPAN NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 371. JAPAN NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 372. JAPAN NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 373. JAPAN NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 374. JAPAN NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 375. JAPAN NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
  • TABLE 376. JAPAN NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 377. JAPAN NUTRIGENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 378. AUSTRALIA NUTRIGENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 379. AUSTRALIA NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 380. AUSTRALIA NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 381. AUSTRALIA NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 382. AUSTRALIA NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 383. AUSTRALIA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 384. AUSTRALIA NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 385. AUSTRALIA NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 386. AUSTRALIA NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
  • TABLE 387. AUSTRALIA NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 388. AUSTRALIA NUTRIGENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 389. SOUTH KOREA NUTRIGENOMICS MARKET SIZE, 20